Tumor-infiltrating lymphocytes to predict survival to anthracycline/taxane-based adjuvant chemotherapy in triple negative breast cancer.

被引：0
|
作者：
Ou, Qiyun
Yu, Yunfang
Xiao, Xiaoyun
Luo, Baoming
机构：
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ultrasonog, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prognostic and predictive value of tumor-infiltrating lymphocytes in triple negative breast cancer
    Kim, E.
    Kwon, J.
    Byon, W.
    Song, B. J.
    Park, C.
    [J]. BREAST, 2015, 24 : S106 - S106
  • [32] Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Si-Lin K.
    Kiley L.
    Kamis S.
    Iqbal J.
    Dent R.
    Sim Y.Y.
    [J]. Current Breast Cancer Reports, 2015, 7 (4) : 232 - 241
  • [33] Spatial organization of tumor-infiltrating lymphocytes (TILs) is prognostic for survival in triple negative breast cancer (TNBC)
    Patel, Sahil H.
    Corredor, German
    Yoder, Rachel
    Barrera, Cristian
    Castillo, Miluska
    Bernabe, Luis
    Staley, Joshua
    Stecklein, Shane
    Viswanath, Satish E.
    Castaneda, Carlos A.
    Sharma, Priyanka
    Madabhushi, Anant
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [34] Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis
    Wang, Ke
    Xu, Jianjun
    Zhang, Tao
    Xue, Dan
    [J]. ONCOTARGET, 2016, 7 (28) : 44288 - 44298
  • [35] A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer
    Criscitiello, C.
    Bayar, M. A.
    Curigliano, G.
    Symmans, F. W.
    Desmedt, C.
    Bonnefoi, H.
    Sinn, B.
    Pruneri, G.
    Vicier, C.
    Pierga, J. Y.
    Denkert, C.
    Loibl, S.
    Sotiriou, C.
    Michiels, S.
    Andre, F.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (01) : 162 - 169
  • [36] Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer
    Cespedes Feliciano, Elizabeth M.
    Chen, Wendy Y.
    Lee, Valerie
    Albers, Kathleen B.
    Prado, Carla M.
    Alexeeff, Stacey
    Xiao, Jingjie
    Shachar, Shlomit S.
    Caan, Bette J.
    [J]. JAMA ONCOLOGY, 2020, 6 (02) : 264 - 270
  • [37] Prognostic impact of tumor-infiltrating lymphocytes (TIL's) and stromal-infiltrating lymphocytes (SIL's) in triple-negative breast cancer.
    Sherwell-Cabello, Santiago
    Maffuz-Aziz, Antonio
    Camacho-Ramirez, Diego A.
    Bautista-Pina, Veronica
    Rios-Luna, Nina P.
    Labastida-Almendaro, Sonia
    Rodriguez-Cuevas, Sergio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [38] Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
    Castaneda, Carlos A.
    Mittendorf, Elizabeth
    Casavilca, Sandro
    Wu, Yun
    Castillo, Miluska
    Arboleda, Patricia
    Nunez, Teresa
    Guerra, Henry
    Barrionuevo, Carlos
    Dolores-Cerna, Ketty
    Belmar-Lopez, Carolina
    Abugattas, Julio
    Calderon, Gabriela
    De La Cruz, Miguel
    Cotrina, Manuel
    Dunstan, Jorge
    Gomez, Henry L.
    Vidaurre, Tatiana
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2016, 7 (05): : 387 - 394
  • [39] Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy
    Liao, Yuqian
    Liao, Yulu
    Li, Jun
    Xiong, Jianping
    Fan, Ying
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [40] Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy
    Yuqian Liao
    Yulu Liao
    Jun Li
    Jianping Xiong
    Ying Fan
    [J]. Scientific Reports, 10
12345